What is shock liver (ischemic hepatitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Shock liver, also known as ischemic hepatitis, is a condition that occurs when the liver is not receiving enough blood flow, often due to cardiac arrest, hypovolemia, hypotension, or severe congestive heart failure.

Causes and Characteristics

  • It can be caused by various factors, including cardiac dysfunction, hypotension, or hypoperfusion 1.
  • Drug-induced hypotension or hypoperfusion may also contribute to the development of shock liver, with examples including long-acting niacin, cocaine, or methamphetamine 1.
  • The condition is characterized by markedly elevated aminotransferase levels, which respond rapidly to stabilization of the circulatory problem 1.
  • Renal dysfunction and muscle necrosis may also occur simultaneously 1.

Diagnosis and Management

  • Hypoenhancement of the liver parenchyma may be observed on imaging studies, indicating hypoperfusion of the liver 1.
  • Selective hepatic hypoperfusion due to hepatic arterial or portal venous occlusion can be reversible due to the liver's dual blood supply, but may result in liver failure or hepatic infarction 1.
  • The ability to manage the underlying cause of ischemia, such as heart failure, will determine the outcome for these patients, and transplantation is seldom indicated 1.

From the Research

Definition of Shock Liver (Ischemic Hepatitis)

  • Shock liver, also known as ischemic hepatitis or hypoxic hepatitis, is characterized by centrilobular liver cell necrosis and sharply increasing serum aminotransferase levels in a clinical setting of cardiac, circulatory, or respiratory failure 2, 3, 4, 5.
  • It is an acute liver injury caused by hepatic hypoxia, with cardiac failure, respiratory failure, and septic shock being the main underlying conditions 3, 4, 5.

Pathophysiology and Clinical Presentation

  • The pathophysiology of ischemic hepatitis is poorly understood, but it is believed to be the result of a reduction in systemic blood flow, as typically occurs in shock 6.
  • Right-sided heart failure, with resultant hepatic venous congestion, may predispose the liver to hepatic injury induced by a hypotensive event 6.
  • Other hemodynamic mechanisms of hypoxia, such as passive congestion of the liver, arterial hypoxaemia, and dysoxia, play an important role in the development of hypoxic hepatitis 4, 5.

Diagnosis and Prognosis

  • The diagnosis of hypoxic hepatitis is primarily clinical and typically does not require liver biopsy 5.
  • The prognosis is poor, with more than half of patients dying during the hospital stay 4, 5.
  • Early recognition of hypoxic hepatitis and its underlying diseases, and subsequent initiation of therapy, is of central prognostic importance 2.
  • The in-hospital mortality rate is >50%, and the most frequent cause of death is the predisposing condition and not the liver injury itself 5.

Treatment and Management

  • Therapy of hypoxic hepatitis depends primarily on the nature of the underlying condition 4, 5.
  • Successful management includes monitoring for potential complications such as hypoglycemia, hyperglycemia, hyperammonemia, and hepatopulmonary syndrome 2, 5.
  • No specific therapies improving the hepatic function in patients with hypoxic hepatitis are currently established 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hypoxic hepatitis].

Ugeskrift for laeger, 2014

Research

Hypoxic hepatitis.

Liver international : official journal of the International Association for the Study of the Liver, 2012

Research

Hypoxic Hepatitis: A Review and Clinical Update.

Journal of clinical and translational hepatology, 2016

Research

Ischemic hepatitis: clinical presentation and pathogenesis.

The American journal of medicine, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.